Citigroup Has Lowered Expectations for Bath & Body Works (NYSE:BBWI) Stock Price

Key Points

• Citigroup has lowered its price target for Bath & Body Works (NYSE:BBWI) from $42.00 to $40.00 while maintaining a "buy" rating, indicating a potential upside of 33.84% from the current price.
• Other research firms have also adjusted their price targets for Bath & Body Works, with Goldman Sachs lowering theirs to $43.00 and Barclays to $30.00, reflecting a cautious outlook on the stock.
• Bath & Body Works reported quarterly earnings of $0.49 per share, surpassing analyst expectations, despite a slight revenue miss with $1.40 billion reported against $1.42 billion expected.

Bath & Body Works (NYSE:BBWI - Get Free Report) had its price target reduced by equities researchers at Citigroup from $42.00 to $40.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a "buy" rating on the stock. Citigroup's price objective would suggest a potential upside of 33.84% from the company's current price.

Several other research firms also recently commented on BBWI. The Goldman Sachs Group decreased their price objective on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday, May 30th. Wall Street Zen downgraded Bath & Body Works from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Morgan Stanley reduced their price objective on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research note on Tuesday, May 6th. UBS Group upped their price target on Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a research report on Tuesday, May 20th. Finally, Barclays dropped their price objective on Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a report on Friday, May 30th. Fourteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $42.06.

Bath & Body Works Stock Performance

Shares of NYSE BBWI traded down $0.2740 during mid-day trading on Tuesday, reaching $29.8860. The company had a trading volume of 1,352,088 shares, compared to its average volume of 5,082,026. Bath & Body Works has a one year low of $24.94 and a one year high of $41.87. The firm has a market cap of $6.32 billion, a price-to-earnings ratio of 7.97, a PEG ratio of 0.96 and a beta of 1.54. The business's 50-day simple moving average is $29.99 and its 200 day simple moving average is $31.16.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The firm had revenue of $1.40 billion for the quarter, compared to analysts' expectations of $1.42 billion. During the same quarter in the previous year, the business posted $0.38 earnings per share. The business's revenue for the quarter was up 2.9% on a year-over-year basis. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. On average, sell-side analysts anticipate that Bath & Body Works will post 3.3 EPS for the current year.

Institutional Trading of Bath & Body Works

Several hedge funds have recently bought and sold shares of BBWI. Mariner LLC grew its holdings in Bath & Body Works by 14.1% during the 4th quarter. Mariner LLC now owns 23,366 shares of the company's stock valued at $906,000 after buying an additional 2,887 shares in the last quarter. Marshall Wace LLP bought a new stake in Bath & Body Works during the 4th quarter valued at $628,000. Canada Pension Plan Investment Board boosted its position in Bath & Body Works by 43.7% during the 4th quarter. Canada Pension Plan Investment Board now owns 77,300 shares of the company's stock valued at $2,997,000 after acquiring an additional 23,500 shares in the last quarter. First Trust Advisors LP boosted its position in Bath & Body Works by 99.6% during the 4th quarter. First Trust Advisors LP now owns 550,759 shares of the company's stock valued at $21,353,000 after acquiring an additional 274,876 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in Bath & Body Works by 17.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,144,292 shares of the company's stock valued at $83,135,000 after acquiring an additional 313,092 shares in the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.